◆ NeutralHIMS
HIMS Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages HIMS Investors with Losses to Contact the Firm
GlobeNewswire Inc.·
A securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. (HIMS) for allegedly making materially false statements about its privacy practices. The FTC accused HIMS of sharing customers' medical information with third-party advertisers including Meta and Snap. Following the FTC lawsuit announcement on July 29, 2026, HIMS stock declined 14.73%. Investors who purchased HIMS securities between August 4, 2025 and July 29, 2026 can seek lead plaintiff status by November 2, 2026.
Read Full Article at GlobeNewswire Inc. →